View in EDS

Disrupting N-Glycosylation Using Type I Mannosidase Inhibitors Alters B-Cell Receptor Signaling.

Saved in:

Bibliographic Details
Title:	Disrupting N-Glycosylation Using Type I Mannosidase Inhibitors Alters B-Cell Receptor Signaling.
Authors:	Huang A; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States., Kurhade SE; Department of Medicinal Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States., Ross P; Department of Medicinal Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States., Apley KD; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States., Griffin JD; Bioengineering Program, The University of Kansas, Lawrence, Kansas 66045, United States., Berkland CJ; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States.; Bioengineering Program, The University of Kansas, Lawrence, Kansas 66045, United States.; Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66045, United States., Farrell MP; Department of Medicinal Chemistry, The University of Kansas, Lawrence, Kansas 66047, United States.
Source:	ACS pharmacology & translational science [ACS Pharmacol Transl Sci] 2022 Oct 25; Vol. 5 (11), pp. 1062-1069. Date of Electronic Publication: 2022 Oct 25 (Print Publication: 2022).
Publication Type:	Journal Article
Journal Info:	Publisher: American Chemical Society Country of Publication: United States NLM ID: 101721411 Publication Model: eCollection Cited Medium: Internet ISSN: 2575-9108 (Electronic) Linking ISSN: 25759108 NLM ISO Abbreviation: ACS Pharmacol Transl Sci Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2575-9108
DOI:	10.1021/acsptsci.2c00153